Codexis Inc (CDXS)
3.56
-0.36
(-9.18%)
USD |
NASDAQ |
May 06, 16:00
3.57
+0.01
(+0.28%)
After-Hours: 07:58
Codexis Free Cash Flow: -54.22M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -54.22M |
| December 31, 2023 | -57.06M |
| September 30, 2023 | -41.45M |
| June 30, 2023 | -6.045M |
| March 31, 2023 | 7.501M |
| December 31, 2022 | 2.977M |
| September 30, 2022 | -6.793M |
| June 30, 2022 | -29.41M |
| March 31, 2022 | -35.38M |
| December 31, 2021 | -28.10M |
| September 30, 2021 | -26.26M |
| June 30, 2021 | -26.30M |
| March 31, 2021 | -27.02M |
| December 31, 2020 | -20.21M |
| September 30, 2020 | -21.31M |
| June 30, 2020 | -20.11M |
| March 31, 2020 | -15.18M |
| December 31, 2019 | -16.29M |
| September 30, 2019 | -13.63M |
| June 30, 2019 | -12.42M |
| March 31, 2019 | -15.96M |
| December 31, 2018 | -16.86M |
| September 30, 2018 | -8.064M |
| June 30, 2018 | -11.14M |
| March 31, 2018 | -10.14M |
| Date | Value |
|---|---|
| December 31, 2017 | -9.74M |
| September 30, 2017 | -12.06M |
| June 30, 2017 | -14.67M |
| March 31, 2017 | -6.505M |
| December 31, 2016 | -2.748M |
| September 30, 2016 | -1.565M |
| June 30, 2016 | 6.284M |
| March 31, 2016 | 2.222M |
| December 31, 2015 | -1.632M |
| September 30, 2015 | -2.938M |
| June 30, 2015 | -1.734M |
| March 31, 2015 | -1.455M |
| December 31, 2014 | 0.019M |
| September 30, 2014 | -9.553M |
| June 30, 2014 | -19.42M |
| March 31, 2014 | -23.06M |
| December 31, 2013 | -24.17M |
| September 30, 2013 | -24.58M |
| June 30, 2013 | -20.18M |
| March 31, 2013 | -16.85M |
| December 31, 2012 | -14.82M |
| September 30, 2012 | -15.61M |
| June 30, 2012 | -12.54M |
| March 31, 2012 | -19.14M |
| December 31, 2011 | -11.23M |
Free Cash Flow Range, Past 5 Years
-57.06M
Minimum
Dec 2023
7.501M
Maximum
Mar 2023
-22.33M
Average
-20.76M
Median
Free Cash Flow Benchmarks
| Avidity Biosciences Inc | -123.29M |
| Taysha Gene Therapies Inc | -80.39M |
| Janux Therapeutics Inc | -52.42M |
| Tango Therapeutics Inc | -119.51M |
| 2seventy bio Inc | -180.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.789M |
| Cash from Investing (Quarterly) | -28.56M |
| Cash from Financing (Quarterly) | 29.28M |
| Free Cash Flow Per Share (Quarterly) | -0.1277 |
| Free Cash Flow to Equity (Quarterly) | -37.02M |
| Free Cash Flow to Firm (Quarterly) | -8.919M |
| Free Cash Flow Yield | -22.04% |